Ironwood Pharmaceuticals Ownership | Who Owns Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals Ownership Summary
Ironwood Pharmaceuticals is owned by 97.08% institutional investors, 1.81% insiders, and 1.11% retail investors. Blackrock is the largest institutional shareholder, holding 14.51% of IRWD shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.66% of its assets in Ironwood Pharmaceuticals shares.
IRWD Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Ironwood Pharmaceuticals | 97.08% | 1.81% | 1.11% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Specialty & Generic Drug Manufacturers Stocks | 26.69% | 10.91% | 62.39% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 22.88M | 14.51% | $149.16M |
| Blackrock funding, inc. /de | 23.04M | 14.42% | $102.06M |
| Vanguard group | 19.54M | 12.23% | $86.56M |
| Sarissa capital management lp | 16.39M | 10.26% | $72.61M |
| Pacer advisors | 11.73M | 7.35% | $51.97M |
| Armistice capital | 9.47M | 5.93% | $41.94M |
| State street | 9.24M | 5.86% | $60.26M |
| Renaissance | 9.07M | 5.68% | $40.16M |
| Braidwell lp | 5.44M | 3.41% | $24.10M |
| Morgan stanley | 4.86M | 3.08% | $31.69M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Sarissa capital management lp | 16.39M | 22.49% | $72.61M |
| Stonepine capital management | 648.78K | 2.32% | $2.87M |
| Saturn v capital management | 814.53K | 1.41% | $3.61M |
| Kynam capital management, lp | 4.69M | 1.23% | $20.76M |
| Sio capital management | 907.78K | 1.13% | $4.02M |
| Braidwell lp | 5.44M | 0.71% | $24.10M |
| Armistice capital | 9.47M | 0.57% | $41.94M |
| Parkman healthcare partners | 408.54K | 0.24% | $1.81M |
| Virtus etf advisers | 98.22K | 0.18% | $435.11K |
| Myda advisors | 115.20K | 0.13% | $510.34K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Morgan stanley | 4.86M | 0.00% | 2.18M |
| Armistice capital | 9.47M | 0.57% | 1.27M |
| Millennium management | 2.18M | 0.00% | 1.25M |
| Ubs group | 2.18M | 0.00% | 1.23M |
| Point72 asset management | 1.15M | 0.01% | 1.15M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| State street | 9.24M | 0.00% | -4.67M |
| Brown capital management | - | - | -2.58M |
| Vanguard group | 19.54M | 0.00% | -2.50M |
| Glenmede trust co na | - | - | -1.40M |
| Blackrock | 22.88M | 0.00% | -1.28M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Point72 asset management | 1.15M | 0.01% | 1.15M | $5.10M |
| Sio capital management | 907.78K | 1.13% | 907.78K | $4.02M |
| Federated hermes | 370.48K | 0.00% | 370.48K | $1.64M |
| Norges bank | 252.29K | 0.00% | 252.29K | $1.12M |
| Myda advisors | 115.20K | 0.13% | 115.20K | $510.34K |
Sold Out
| Holder | Change |
|---|---|
| Natixis | -2.00 |
| Sjs investment consulting | -5.00 |
| Jfs wealth advisors | -10.00 |
| Mendota financial group | -11.00 |
| Dinuzzo private wealth | -15.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 213 | -3.62% | 155,039,542 | -4.94% | 97 | 0.93% | 110 | 4.76% | 71 | -7.79% |
| Sep 30, 2024 | 220 | -4.76% | 163,072,766 | -4.90% | 102 | 0.86% | 104 | -9.57% | 77 | -2.53% |
| Jun 30, 2024 | 231 | -19.23% | 171,479,228 | -0.14% | 108 | 0.92% | 115 | -22.30% | 79 | -3.66% |
| Mar 31, 2024 | 286 | 8.75% | 171,721,700 | 4.08% | 108 | 0.97% | 148 | 21.31% | 82 | -10.87% |
| Dec 31, 2023 | 263 | 3.54% | 164,991,549 | 2.21% | 106 | 0.99% | 122 | 7.96% | 92 | -9.80% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 9.06M | 5.66% | - |
| Vanguard Total Stock Mkt Idx Inv | 4.19M | 2.62% | - |
| Vanguard US Total Market Shares ETF | 4.18M | 2.59% | - |
| iShares Russell 2000 ETF | 3.86M | 2.39% | -33.49K |
| SPDR® S&P Biotech ETF | 2.51M | 1.57% | -15.31K |
| Vanguard Strategic Equity Inv | 2.45M | 1.53% | 140.66K |
| Vanguard Institutional Extnd Mkt Idx Tr | 2.25M | 1.41% | 4.18K |
| Vanguard Explorer Inv | 2.23M | 1.40% | - |
| Pacer US Small Cap Cash Cows 100 ETF | 1.79M | 1.11% | -11.72K |
| Vanguard Small Cap Index | 1.74M | 1.09% | 1.41K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 10, 2025 | MCCOURT Thomas A | Chief Executive Officer | Sell | $244.75K |
| Feb 10, 2025 | Silver Ronald | Principal Accounting Officer | Sell | $21.20K |
| Feb 10, 2025 | Shetzline Michael | SVP, CMO, Head-Res&Drug | Sell | $72.63K |
| Feb 10, 2025 | John Minardo | Chief Legal Officer | Sell | $68.53K |
| Feb 10, 2025 | Martini Gregory S. | Chief Financial Officer | Sell | $21.21K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | 5 |
| 2024 Q4 | - | 2 |
| 2024 Q3 | - | 2 |
| 2024 Q2 | - | 7 |
| 2024 Q1 | 2 | 5 |
IRWD Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools